These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
366 related items for PubMed ID: 25299785
1. New OPTN/UNOS classification system for nodules in cirrhotic livers detected with MR imaging: effect on hepatocellular carcinoma detection and transplantation allocation. Rosenkrantz AB, Campbell N, Wehrli N, Triolo MJ, Kim S. Radiology; 2015 Feb; 274(2):426-33. PubMed ID: 25299785 [Abstract] [Full Text] [Related]
2. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings. Lee DH, Lee JM, Baek JH, Shin CI, Han JK, Choi BI. Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131 [Abstract] [Full Text] [Related]
3. Concordance of hypervascular liver nodule characterization between the organ procurement and transplant network and liver imaging reporting and data system classifications. Bashir MR, Huang R, Mayes N, Marin D, Berg CL, Nelson RC, Jaffe TA. J Magn Reson Imaging; 2015 Aug; 42(2):305-14. PubMed ID: 25371354 [Abstract] [Full Text] [Related]
4. Validation of organ procurement and transplant network (OPTN)/united network for organ sharing (UNOS) criteria for imaging diagnosis of hepatocellular carcinoma. Fowler KJ, Karimova EJ, Arauz AR, Saad NE, Brunt EM, Chapman WC, Heiken JP. Transplantation; 2013 Jun 27; 95(12):1506-11. PubMed ID: 23778569 [Abstract] [Full Text] [Related]
5. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis. Hecht EM, Holland AE, Israel GM, Hahn WY, Kim DC, West AB, Babb JS, Taouli B, Lee VS, Krinsky GA. Radiology; 2006 May 27; 239(2):438-47. PubMed ID: 16641353 [Abstract] [Full Text] [Related]
7. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Holland AE, Hecht EM, Hahn WY, Kim DC, Babb JS, Lee VS, West AB, Krinsky GA. Radiology; 2005 Dec 27; 237(3):938-44. PubMed ID: 16306035 [Abstract] [Full Text] [Related]
8. Hepatocellular carcinoma with indeterminate or false-negative findings at initial MR imaging: effect on eligibility for curative treatment initial observations. Choi D, Mitchell DG, Verma SK, Bergin D, Navarro VJ, Malliah AB, McGowan C, Hann HW, Herrine SK. Radiology; 2007 Sep 27; 244(3):776-83. PubMed ID: 17690322 [Abstract] [Full Text] [Related]
10. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver. Yoo HJ, Lee JM, Lee JY, Kim SH, Kim SJ, Han JK, Choi BI. Invest Radiol; 2009 Dec 27; 44(12):800-7. PubMed ID: 19838119 [Abstract] [Full Text] [Related]
11. Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis. Di Martino M, Marin D, Guerrisi A, Baski M, Galati F, Rossi M, Brozzetti S, Masciangelo R, Passariello R, Catalano C. Radiology; 2010 Sep 27; 256(3):806-16. PubMed ID: 20720069 [Abstract] [Full Text] [Related]
12. Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings. Ishigami K, Yoshimitsu K, Nishihara Y, Irie H, Asayama Y, Tajima T, Nishie A, Hirakawa M, Ushijima Y, Okamoto D, Taketomi A, Honda H. Radiology; 2009 Feb 27; 250(2):435-43. PubMed ID: 19095782 [Abstract] [Full Text] [Related]
14. Transplantation for hepatocellular carcinoma and cirrhosis: sensitivity of magnetic resonance imaging. Krinsky GA, Lee VS, Theise ND, Weinreb JC, Morgan GR, Diflo T, John D, Teperman LW, Goldenberg AS. Liver Transpl; 2002 Dec 27; 8(12):1156-64. PubMed ID: 12474156 [Abstract] [Full Text] [Related]
15. Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI. Choi SH, Lee JM, Yu NC, Suh KS, Jang JJ, Kim SH, Choi BI. AJR Am J Roentgenol; 2008 Aug 27; 191(2):529-36. PubMed ID: 18647927 [Abstract] [Full Text] [Related]
16. Hepatocellular carcinoma in cirrhotic liver: double-contrast-enhanced, high-resolution 3.0T-MR imaging with pathologic correlation. Yoo HJ, Lee JM, Lee MW, Kim SJ, Lee JY, Han JK, Choi BI. Invest Radiol; 2008 Jul 27; 43(7):538-46. PubMed ID: 18580337 [Abstract] [Full Text] [Related]
17. Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US. Darnell A, Forner A, Rimola J, Reig M, García-Criado Á, Ayuso C, Bruix J. Radiology; 2015 Jun 27; 275(3):698-707. PubMed ID: 25658038 [Abstract] [Full Text] [Related]
18. Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study. Figueras J, Ibañez L, Ramos E, Jaurrieta E, Ortiz-de-Urbina J, Pardo F, Mir J, Loinaz C, Herrera L, López-Cillero P, Santoyo J. Liver Transpl; 2001 Oct 27; 7(10):877-83. PubMed ID: 11679986 [Abstract] [Full Text] [Related]
19. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Figueras J, Jaurrieta E, Valls C, Benasco C, Rafecas A, Xiol X, Fabregat J, Casanovas T, Torras J, Baliellas C, Ibañez L, Moreno P, Casais L. Hepatology; 1997 Jun 27; 25(6):1485-9. PubMed ID: 9185772 [Abstract] [Full Text] [Related]
20. Diagnostic Performance of Gadoxetic Acid-enhanced Liver MR Imaging versus Multidetector CT in the Detection of Dysplastic Nodules and Early Hepatocellular Carcinoma. Kim BR, Lee JM, Lee DH, Yoon JH, Hur BY, Suh KS, Yi NJ, Lee KB, Han JK. Radiology; 2017 Oct 27; 285(1):134-146. PubMed ID: 28609205 [Abstract] [Full Text] [Related] Page: [Next] [New Search]